Capital Markets Day

RNS Number : 5630N
Science in Sport PLC
21 January 2019
 

 

SCIENCE IN SPORT PLC

 

("SIS", the "Company" or the "Group")

 

Capital Markets Day

 

Science in Sport plc (AIM: SIS), a UK-headquartered market-leading performance nutrition company that develops, manufactures and markets sports nutrition products for elite athletes and sports and gym lifestyle enthusiasts, will be hosting a Capital Markets Day ("CMD") on Thursday 24th January, 2019.

 

The CMD will be hosted by Stephen Moon, Chief Executive Officer, alongside other members of the Executive Committee, and will provide attendees with an overview of the business and its strategy following the acquisition of PhD Nutrition which completed in early December. There will be an opportunity for Q&A as well as a product tasting session.

 

No material new information will be made public and the presentation will be made available on the Company's website at https://www.scienceinsport.com/help/investors.

 

The event is being held between the hours of 12:00 and 15:00 at the offices of Instinctif Partners, 65 Gresham Street, London, EC2V 7NQ. Lunch will be provided.

 

To register your attendance, please contact tom.berger@instinctif.com

 

Presenters during the course of the afternoon will be:

 

Stephen Moon

Chief Executive Officer

Ashley Read

Managing Director, Science in Sport

Jason Rickaby

Founder & Managing Director, PhD

Simon Freedman

Head of Football

Dr. James Morton

World Class Knowledge Director

Mark McKechnie

E-Commerce Director

Craig Fletcher

Supply Chain Director

Elizabeth Lake

Chief Financial Officer

 

 

21 January 2019

 

For further information, please contact:

 

Science in Sport PLC

Stephen Moon, CEO

Elizabeth Lake, CFO

 

Tel: +44 (0) 20 7400 3700

Liberum
(Nominated Adviser & Broker)

Clayton Bush

Chris Clarke

James Greenwood

 

Tel: +44 (0) 20 3100 2000

Instinctif Partners

(Financial PR)

Matthew Smallwood

Tom Berger

Tel: +44 (0) 20 7457 2020

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBPMRTMBJBBLL
UK 100

Latest directors dealings